BaiFu Laser Secures Tens of Millions in Series B Funding from Daxing Airport Economic Zone Development Fund to Accelerate Global Expansion of Domestic Aesthetic Photonic Devices

Suzhou BVLASER Laser Technology Co., Ltd. (“BVLASER”) recently announced the completion of its Series B financing round, raising tens of millions of yuan. The investment was made by the Daxing Airport Economic Zone Development Fund, managed by Beijing New Airport City Fund Management Co., Ltd. (“New Airport City Fund Company”), a subsidiary of Beijing New Airport City Holdings Co., Ltd. Zhoudu Capital served as the exclusive financial advisor for this financing round.

Since its establishment in 2021, BVLASER has secured over RMB 100 million in investment from prominent investors such as Northern Light Venture Capital and Yuansheng Venture Capital. The funds from this round will be utilized for the research, development, and regulatory filing of new products; expansion into overseas markets and brand building; and the initial establishment of domestic distribution channels, thereby accelerating the global deployment of BVLASER’s self-developed equipment.

The photoelectric aesthetics market, with its unique blend of medical and consumer attributes, has attracted a broad consumer base and become the preferred entry point for many individuals seeking their first aesthetic medicine treatment. The founding team of BVLASER has been deeply engaged in the photoelectric aesthetic medicine sector for over a decade, gaining profound insights into industry challenges such as the mismatch between high market demand and low equipment supply, as well as the low rate of domestic production. Therefore, the company is committed to independent innovation and mastering core R&D technologies, marking a significant step in bringing domestically produced equipment to the global market. BVLASER’s current product portfolio includes 1064 nm and 532 nm picosecond lasers, Nd:YAG Q-switched lasers, 755 nm alexandrite long-pulse lasers, 2940 nm erbium lasers, and 1927 nm thulium lasers. The performance and technical specifications of these products have reached a leading level within China.

BVLASER adheres to a dual-drive strategy of technology and market expansion, with its products now exported to over 70 countries and regions worldwide. In the European and American markets, characterized by high market maturity and a distinct preference for high-end instruments, BVLASER has achieved significant success amidst intense competition from industry giants, leveraging its exceptional technological innovation and high-quality products. This segment contributes the majority of the company's overseas revenue. Upholding its commitment to bringing domestically produced high-end medical aesthetic devices to the global stage, BVLASER continues to deepen its presence in Europe and America while expanding into high-potential markets such as West Asia and South Asia, thereby sustaining rapid annual performance growth and maintaining strong profitability.

Jia Yangchun, Founder of BVLASERstated: "We sincerely appreciate the recognition from the New Airport City Fund. The BVLASER team will continue to strive toward our goal of becoming a world-class enterprise in medical aesthetic optoelectronics."

New Airport City Fund Company is a professional investment institution under Beijing New Airport City Holdings Co., Ltd. Adhering to the investment philosophy of “industry guidance + investment returns,” the company is committed to identifying and attracting high-quality projects to settle in the Airport Economic Zone. While providing preferential policies and facilitating business growth, it aims to build a professional capital investment and operation platform, continuously injecting new momentum into the development of the industrial ecosystem in the Airport Economic Zone.